Tiagabine Hydrochloride Tablet — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Tiagabine Hydrochloride Tablet (tablet) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Apr 15, 2026.

Shortage details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0093-8076-56
Dosage Form
Tablet
Presentation
Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)
Initial Posting
Apr 15, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.